Multicenter Phase II Clinical Trial of Sorafenib Combined with TACE for Advanced Stage HCC (STAB Study)

PURPOSE To evaluate the safety and efficacy of combination therapy (TACE+ sorafenib) in patients with advanced stage HCC. STUDY DESIGN Open-label, non-randomized, single-arm multicenter phase II clinical trial. The primary endpoint was defined as the rate of completion of the treatment protocol (i.e., 2 months duration of sorafenib following TACE); Read more…

IR Research in Residency With Tyler Mandt, MD PGY-2 – Integrated IR Residency University of California, San Diego

Tell me a little about yourself. I am originally from Seattle. I received my undergrad degree in bioengineering at the University of Washington in Seattle and then spent 4.5 years in an immunology lab at Seattle Children’s Hospital performing high fidelity genome editing research before CRISPER/CAS9. The idea was to Read more…

Military Match and IR

Written by: Chris Choe, University of Tennessee College of Medicine MS3 Rose Miller, The Ohio State University College of Medicine, MS3   General Overview about Military Match While currently a rare topic of discussion, IR opportunities in the military are increasing. Medical students choose a career in military medicine for various reasons. For many Read more…